파이로젠(발열성 물질) 검사 시장 : 제품 및 서비스별, 검사 유형별, 최종 사용자별 - 세계 기회 분석 및 산업 예측(2023-2032년)

Pyrogen Testing Market By Product and Service, By Test Type, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

US $ 5,730 ￦ 7,833,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 9,600 ￦ 13,124,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

파이로젠 검사는 엔도톡신 검출을 위해 일반적으로 사용되는 Limulus amebocyte lysate(LAL) 시험과 같은 박테리아 유래 물질을 이용한 시험관내(in vitro) 방법을 포함합니다.

다른 방법으로는 단구 활성화 시험(MAT)과 토끼 파이로젠 검사 등이 있지만, 윤리적인 문제나 보다 민감하고 특이적인 대체법이 있기 때문에 별로 사용되지 않습니다. 파이로젠 검사의 목적은 환자의 건강을 손상시킬 수 있는 파이로젠 오염물질에 대한 노출을 방지함으로써 의료 제품의 안전과 품질을 보장하는 것입니다.

파이로젠 검사 시장의 성장을 가속하는 주요 요인으로는 의약품이나 의료기기의 안전성과 품질 확보를 중시하는 경향이 높아지고, 심장병, 당뇨병, 관절염, 암, 당뇨병 등의 만성 질환의 유병 비율의 급증, 의약품 및 의료기기에 대한 수요 증가 등이 있습니다. 의약품 및 생명공학 산업에서 첨단 제형의 개척은 파이로젠 검사 시장 확대의 중요한 촉진요인입니다. 의약품의 복잡화에 의해 보다 많은 품질 관리 대책의 실시가 필요하게 되어, 파이로젠 검사의 채용으로 이어졌습니다. 또한 복잡한 제제와 최첨단 의료기술을 도입하는 제약 및 바이오 산업 증가로 고도로 민감한 파이로젠 검사 수법의 필요성이 높아지고 있어 이것이 시장 성장의 추진력이 되고 있습니다.

또한, 파이로젠 오염을 최소화하기 위한 이니셔티브 증가로 세계 규제기관과 의료기관은 엄격한 기준을 설정하게 되었습니다. 이 때문에 강력한 파이로젠 검사법의 채용이 의무화되어 파이로젠 검사 시장의 성장에 기여하고 있습니다. 예를 들어, 미국 식품의약국(FDA), 유럽의약청(EMA) 등의 규제당국은 파이로젠 검사에 대한 명확한 지침과 기준을 설정하고 있습니다. 이 지침은 의약품 및 의료기기 제조업체가 품질 관리 프로세스의 일환으로 철저한 파이로젠 검사를 실시하기 위한 규제 당국의 기대와 요건을 개략적으로 설명합니다. 따라서 이러한 지침의 엄격한 준수는 시장 성장에 크게 기여합니다.

또한, 파이로젠 검사에 있어서의 기술적 진보 증가는 시장의 성장을 더욱 뒷받침합니다. 시험관내 방법 및 시험관내 시험, 엔도톡신 시험, 재조합 C 인자 분석 등의 혁신적인 파이로젠 검출 방법의 개발은 파이로젠 검사 프로세스의 정확성과 효율성을 향상시킵니다. 예를 들어, Lonza Group은 파이로젠 검사의 효율성과 정확성을 높이는 첨단 기술을 통합한 자동 엔도톡신 검사 플랫폼인 PyroTec PRO를 제조합니다. 이 시스템은 확립된 Limulus Amoebocyte Lysate(LAL) 시험 방법을 활용하여 시험 프로세스를 자동화하고 간소화합니다. 이러한 기술적 진보로 제약 제조업체는 보다 신뢰성 있고 신속한 검사 절차를 채택할 수 있게 되어 시장 성장을 뒷받침하고 있습니다.

그러나, 파이로젠 검사의 표준화가 제한되어 있는 것이 시장 성장의 방해가 되고 있습니다. 또한, 파이로젠 오염의 위험 및 검사 방법에 대한 지식과 교육의 부족은 신흥 지역에서 파이로젠 검사의 보급을 방해하고 있습니다. 이와는 대조적으로, 혁신과 제품 개발에 초점을 맞춘 의료기기 산업의 확대와 신흥 국가의 높은 성장 가능성은 예측 기간 동안 유리한 기회를 제공할 것으로 기대됩니다.

파이로젠 검사 시장은 제품 및 서비스, 검사 유형, 최종 사용자, 지역에 따라 구분됩니다. 제품 및 서비스별로 시장은 시약 및 키트, 장비, 서비스로 분류됩니다. 검사 유형별로는 LAL 검사, 토끼 파이로젠 검사 등으로 나눌 수 있습니다. 최종 사용자별로는 제약 및 바이오테크놀러지 기업, 의료기기 기업, 기타로 분류됩니다. 지역별로는 북미(미국, 캐나다, 멕시코), 유럽(독일, 프랑스, 영국, 이탈리아, 스페인, 기타 유럽), 아시아태평양(일본, 중국, 호주, 인도, 한국, 기타 아시아태평양), LA(브라질, 콜롬비아, 아르헨티나 및 기타 아시아태평양), MEA(GCC, 남미, 북아프리카 및 기타 MEA 지역)에서 분석됩니다.

이해관계자를 위한 주요 이점

• 본 보고서는 2022년부터 2032년까지의 파이로젠 검사 시장 분석의 시장 부문, 현재의 동향, 추정 및 동향, 역학을 정량적으로 분석하여, 파이로젠 검사 시장의 유력한 기회를 특정합니다.
• 시장 성장 촉진요인, 시장 성장 억제요인, 시장 기회와 관련된 정보와 함께 시장 조사를 제공합니다.
• Porter's Five Forces 분석은 이해관계자가 이익 지향적인 비즈니스 결정을 내리고 공급업체 및 구매자의 네트워크를 강화할 수 있도록 구매자와 공급업체의 잠재력을 강조합니다.
• 파이로젠 검사 시장의 세분화를 상세하게 분석함으로써 시장 기회를 파악할 수 있습니다.
• 각 지역의 주요 국가는 세계 시장에 대한 수익 공헌도에 따라 매핑됩니다.
• 시장 기업 포지셔닝은 벤치마킹을 용이하게 하고 시장 기업의 현재 위치를 명확하게 이해할 수 있습니다.
• 이 보고서에는 지역별 및 세계의 파이로젠 검사 시장 동향, 주요 기업, 시장 부문, 응용 분야 및 시장 성장 전략 분석이 포함되어 있습니다.

이해관계자를 위한 주요 이점

• 본 보고서에서는 2022년부터 2032년까지의 파이로젠 검사 시장 분석의 시장 부문, 현재의 동향, 추정 및 동향, 역학을 정량적으로 분석하여, 파이로젠 검사 시장의 유력한 기회를 특정합니다.
• 시장 성장 촉진요인, 시장 성장 억제요인, 시장 기회와 관련된 정보와 함께 시장 조사를 제공합니다.
• Porter's Five Forces 분석은 이해관계자가 이익 지향적인 비즈니스 결정을 내리고 공급업체 및 구매자의 네트워크를 강화할 수 있도록 구매자와 공급업체의 잠재력을 강조합니다.
• 파이로젠 검사 시장의 세분화를 상세하게 분석함으로써 시장 기회를 파악할 수 있습니다.
• 각 지역의 주요 국가는 세계 시장에 대한 수익 공헌도에 따라 매핑됩니다.
• 시장 기업 포지셔닝은 벤치마킹을 용이하게 하고 시장 기업의 현재 위치를 명확하게 이해할 수 있습니다.
• 이 보고서에는 지역별 및 세계의 파이로젠 검사 시장 동향, 주요 기업, 시장 부문, 응용 분야 및 시장 성장 전략 분석이 포함되어 있습니다.

이 보고서에서 가능한 맞춤설정(추가 비용 및 일정 필요)

• 규제 가이드라인
• 고객의 관심에 따른 기업 프로파일 추가
• 국가별 또는 지역별 추가 분석-시장 규모 및 예측
• 기업 프로파일의 확장 목록
• 과거 시장 데이터
• 주요 기업의 상세(소재지, 연락처, 공급자 및 벤더 네트워크 등을 포함한 엑셀 형식)

목차

제1장 서론

제2장 주요 요약

제3장 시장 개요

• 시장 정의 및 범위
• 주요 조사 결과
  • 영향요인
  • 주요 투자 기회
• Porter's Five Forces 분석
• 시장 역학
  • 성장 촉진요인
  • 억제요인
  • 기회

제4장 파이로젠 검사 시장 : 제품 및 서비스별

• 개요
• 시약 및 키트
• 검사 기기
• 서비스

제5장 파이로젠 검사 시장 : 검사 유형별

• 개요
• LAL 검사
• 토끼 파이로젠 검사(RPT)
• 기타

제6장 파이로젠 검사 시장 : 최종 사용자별

• 개요
• 제약 및 바이오테크놀러지 기업
• 의료기기 기업
• 기타

제7장 파이로젠 검사 시장 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 기타
• 라틴아메리카
  • 브라질
  • 콜롬비아
  • 아르헨티나
  • 기타 라틴아메리카
• 중동 및 아프리카
  • Gcc
  • 남아프리카
  • 북아프리카
  • 기타

제8장 경쟁 구도

• 서문
• 주요 성공 전략
• 주요 10개사의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2022년)

제9장 기업 프로파일

• Lonza Group AG
• Thermo Fisher Scientific Inc.
• Fujifilm Holdings Corporation
• GenScript
• SEIKAGAKU CORPORATION
• Charles River Laboratories
• STERIS plc
• Wuxi AppTec
• Eurofins Scientific SE
• Merck KGaA

AJY

영문 목차

영문목차

Pyrogen testing involves in vitro methods using substances derived from bacterial sources, such as the Limulus amebocyte lysate (LAL) test, which is commonly employed for endotoxin detection. Other methods include the monocyte activation test (MAT) and rabbit pyrogen test, although these are less commonly used due to ethical concerns and the availability of more sensitive and specific alternatives. The goal of pyrogen testing is to ensure the safety and quality of medical products by preventing exposure to pyrogenic contaminants that could compromise patient health.

Key factors that drive the growth of the pyrogen testing market include a rise in emphasis on ensuring the safety and quality of pharmaceutical and medical devices, surge in the prevalence of chronic diseases, such as heart disease, diabetes, arthritis, cancer, & diabetes, and rise in demand for pharmaceuticals & medical devices. The development of advanced formulations in the pharmaceutical and biotechnology industries is a significant driver for the pyrogen testing market expansion. The increase in complexity of pharmaceutical products has necessitated the implementation of more quality control measures, leading to the adoption of pyrogen testing. In addition, the rise in number of pharmaceutical & biotechnology industries introducing complex formulations and cutting-edge medical technologies have led to the need for advanced and sensitive pyrogen testing methodologies, which propel the market growth.

Furthermore, growing initiatives for minimizing pyrogen contamination have led to global regulatory bodies and healthcare organizations to set strict standards. This mandates the adoption of strong pyrogen testing methods, contributing to the growth of the pyrogen testing market. For instance, regulatory authorities, such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and others, have established clear guidelines and standards for pyrogen testing. These guidelines outline the regulatory expectations and requirements for pharmaceutical and medical device manufacturers to conduct thorough pyrogen testing as part of their quality control processes. Thus, stringent adherence to these guidelines contributes significantly to market growth.

Moreover, the rise in technological advancements in pyrogen testing further boosts market growth. The development of innovative pyrogen detection methods, such as in vitro and in vivo testing, endotoxin testing, and recombinant factor C assays, enhances the accuracy and efficiency of pyrogen testing processes. For instance, Lonza Group company manufacture PyroTec PRO, an automated endotoxin testing platform that incorporates advanced technology to enhance the efficiency and accuracy of pyrogen testing. The system utilizes the well-established Limulus Amoebocyte Lysate (LAL) test method automates and streamlines the testing process. These technological advancements enable pharmaceutical manufacturers to adopt more reliable and rapid testing procedures, thereby propelling the market growth.

However, limited standardization for pyrogen testing hinders market growth. In addition, lack of knowledge and education about pyrogen contamination risks and testing methodologies hinder the widespread adoption of pyrogen testing in emerging regions. In contrast, expanding the medical device industry, with a focus on innovation and product development, and high growth potential in emerging countries are expected to provide lucrative opportunities during the forecast period.

The pyrogen testing market is segmented on the basis of product & service, test type, end user, and region. By product & service, the market is classified into reagents & kits, instruments, and services. By test type, the market is divided into LAL tests, rabbit pyrogen test, and others. By end user, it is segregated into pharmaceutical & biotechnology companies, medical device companies, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), LA (Brazil, Colombia, Argentina, and rest of LA), and MEA (GCC, South Africa, North Africa, and rest of MEA).

Major key players that operate in the pyrogen testing market are Merck KGaA, Lonza Group, Thermo Fisher Scientific Inc., FUJIFILM Holdings Corporation, GenScript, SEIKAGAKU CORPORATION, Charles River Laboratories, STERIS, WuXi AppTec, and Eurofins Scientific. Key players have adopted product launch as a key developmental strategy to improve the product portfolio of the pyrogen testing market. For instance, in August 2023, Lonza Group launched the Nebula Absorbance Reader, a new absorbance microplate reader which joins the company's portfolio of optimized instruments for streamlined endotoxin and pyrogen testing.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pyrogen testing market analysis from 2022 to 2032 to identify the prevailing pyrogen testing market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the pyrogen testing market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global pyrogen testing market trends, key players, market segments, application areas, and market growth strategies.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pyrogen testing market analysis from 2022 to 2032 to identify the prevailing pyrogen testing market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the pyrogen testing market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global pyrogen testing market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product and Service

• Reagents and Kits
• Instruments
• Services

By Test Type

• LAL Test
• Rabbit Pyrogen Test
• Others

By End User

• Pharmaceutical and Biotechnology Companies
• Medical Device Companies
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Colombia
  • Argentina
  • Rest Of La
• Middle East and Africa
  • Gcc
  • South Africa
  • North Africa
  • Rest Of Mea

Key Market Players:

• Lonza Group AG
• Thermo Fisher Scientific Inc.
• Fujifilm Holdings Corporation
• GenScript
• SEIKAGAKU CORPORATION
• Charles River Laboratories
• STERIS plc
• Wuxi AppTec
• Eurofins Scientific SE
• Merck KGaA

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. Low bargaining power of suppliers
  • 3.3.2. Low threat of new entrants
  • 3.3.3. Low threat of substitutes
  • 3.3.4. Low intensity of rivalry
  • 3.3.5. Low bargaining power of buyers
• 3.4. Market dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities

CHAPTER 4: PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Reagents and Kits
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
• 4.3. Instruments
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country
• 4.4. Services
  • 4.4.1. Key market trends, growth factors and opportunities
  • 4.4.2. Market size and forecast, by region
  • 4.4.3. Market share analysis by country

CHAPTER 5: PYROGEN TESTING MARKET, BY TEST TYPE

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. LAL Test
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Rabbit Pyrogen Test
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country
• 5.4. Others
  • 5.4.1. Key market trends, growth factors and opportunities
  • 5.4.2. Market size and forecast, by region
  • 5.4.3. Market share analysis by country

CHAPTER 6: PYROGEN TESTING MARKET, BY END USER

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Pharmaceutical and Biotechnology Companies
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
• 6.3. Medical Device Companies
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country
• 6.4. Others
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by region
  • 6.4.3. Market share analysis by country

CHAPTER 7: PYROGEN TESTING MARKET, BY REGION

• 7.1. Overview
  • 7.1.1. Market size and forecast By Region
• 7.2. North America
  • 7.2.1. Key market trends, growth factors and opportunities
  • 7.2.2. Market size and forecast, by Product and Service
  • 7.2.3. Market size and forecast, by Test Type
  • 7.2.4. Market size and forecast, by End User
  • 7.2.5. Market size and forecast, by country
    • 7.2.5.1. U.S.
    • 7.2.5.1.1. Market size and forecast, by Product and Service
    • 7.2.5.1.2. Market size and forecast, by Test Type
    • 7.2.5.1.3. Market size and forecast, by End User
    • 7.2.5.2. Canada
    • 7.2.5.2.1. Market size and forecast, by Product and Service
    • 7.2.5.2.2. Market size and forecast, by Test Type
    • 7.2.5.2.3. Market size and forecast, by End User
    • 7.2.5.3. Mexico
    • 7.2.5.3.1. Market size and forecast, by Product and Service
    • 7.2.5.3.2. Market size and forecast, by Test Type
    • 7.2.5.3.3. Market size and forecast, by End User
• 7.3. Europe
  • 7.3.1. Key market trends, growth factors and opportunities
  • 7.3.2. Market size and forecast, by Product and Service
  • 7.3.3. Market size and forecast, by Test Type
  • 7.3.4. Market size and forecast, by End User
  • 7.3.5. Market size and forecast, by country
    • 7.3.5.1. Germany
    • 7.3.5.1.1. Market size and forecast, by Product and Service
    • 7.3.5.1.2. Market size and forecast, by Test Type
    • 7.3.5.1.3. Market size and forecast, by End User
    • 7.3.5.2. France
    • 7.3.5.2.1. Market size and forecast, by Product and Service
    • 7.3.5.2.2. Market size and forecast, by Test Type
    • 7.3.5.2.3. Market size and forecast, by End User
    • 7.3.5.3. UK
    • 7.3.5.3.1. Market size and forecast, by Product and Service
    • 7.3.5.3.2. Market size and forecast, by Test Type
    • 7.3.5.3.3. Market size and forecast, by End User
    • 7.3.5.4. Italy
    • 7.3.5.4.1. Market size and forecast, by Product and Service
    • 7.3.5.4.2. Market size and forecast, by Test Type
    • 7.3.5.4.3. Market size and forecast, by End User
    • 7.3.5.5. Spain
    • 7.3.5.5.1. Market size and forecast, by Product and Service
    • 7.3.5.5.2. Market size and forecast, by Test Type
    • 7.3.5.5.3. Market size and forecast, by End User
    • 7.3.5.6. Rest of Europe
    • 7.3.5.6.1. Market size and forecast, by Product and Service
    • 7.3.5.6.2. Market size and forecast, by Test Type
    • 7.3.5.6.3. Market size and forecast, by End User
• 7.4. Asia-Pacific
  • 7.4.1. Key market trends, growth factors and opportunities
  • 7.4.2. Market size and forecast, by Product and Service
  • 7.4.3. Market size and forecast, by Test Type
  • 7.4.4. Market size and forecast, by End User
  • 7.4.5. Market size and forecast, by country
    • 7.4.5.1. Japan
    • 7.4.5.1.1. Market size and forecast, by Product and Service
    • 7.4.5.1.2. Market size and forecast, by Test Type
    • 7.4.5.1.3. Market size and forecast, by End User
    • 7.4.5.2. China
    • 7.4.5.2.1. Market size and forecast, by Product and Service
    • 7.4.5.2.2. Market size and forecast, by Test Type
    • 7.4.5.2.3. Market size and forecast, by End User
    • 7.4.5.3. India
    • 7.4.5.3.1. Market size and forecast, by Product and Service
    • 7.4.5.3.2. Market size and forecast, by Test Type
    • 7.4.5.3.3. Market size and forecast, by End User
    • 7.4.5.4. Australia
    • 7.4.5.4.1. Market size and forecast, by Product and Service
    • 7.4.5.4.2. Market size and forecast, by Test Type
    • 7.4.5.4.3. Market size and forecast, by End User
    • 7.4.5.5. South Korea
    • 7.4.5.5.1. Market size and forecast, by Product and Service
    • 7.4.5.5.2. Market size and forecast, by Test Type
    • 7.4.5.5.3. Market size and forecast, by End User
    • 7.4.5.6. Rest of Asia-Pacific
    • 7.4.5.6.1. Market size and forecast, by Product and Service
    • 7.4.5.6.2. Market size and forecast, by Test Type
    • 7.4.5.6.3. Market size and forecast, by End User
• 7.5. Latin America
  • 7.5.1. Key market trends, growth factors and opportunities
  • 7.5.2. Market size and forecast, by Product and Service
  • 7.5.3. Market size and forecast, by Test Type
  • 7.5.4. Market size and forecast, by End User
  • 7.5.5. Market size and forecast, by country
    • 7.5.5.1. Brazil
    • 7.5.5.1.1. Market size and forecast, by Product and Service
    • 7.5.5.1.2. Market size and forecast, by Test Type
    • 7.5.5.1.3. Market size and forecast, by End User
    • 7.5.5.2. Colombia
    • 7.5.5.2.1. Market size and forecast, by Product and Service
    • 7.5.5.2.2. Market size and forecast, by Test Type
    • 7.5.5.2.3. Market size and forecast, by End User
    • 7.5.5.3. Argentina
    • 7.5.5.3.1. Market size and forecast, by Product and Service
    • 7.5.5.3.2. Market size and forecast, by Test Type
    • 7.5.5.3.3. Market size and forecast, by End User
    • 7.5.5.4. Rest Of La
    • 7.5.5.4.1. Market size and forecast, by Product and Service
    • 7.5.5.4.2. Market size and forecast, by Test Type
    • 7.5.5.4.3. Market size and forecast, by End User
• 7.6. Middle East and Africa
  • 7.6.1. Key market trends, growth factors and opportunities
  • 7.6.2. Market size and forecast, by Product and Service
  • 7.6.3. Market size and forecast, by Test Type
  • 7.6.4. Market size and forecast, by End User
  • 7.6.5. Market size and forecast, by country
    • 7.6.5.1. Gcc
    • 7.6.5.1.1. Market size and forecast, by Product and Service
    • 7.6.5.1.2. Market size and forecast, by Test Type
    • 7.6.5.1.3. Market size and forecast, by End User
    • 7.6.5.2. South Africa
    • 7.6.5.2.1. Market size and forecast, by Product and Service
    • 7.6.5.2.2. Market size and forecast, by Test Type
    • 7.6.5.2.3. Market size and forecast, by End User
    • 7.6.5.3. North Africa
    • 7.6.5.3.1. Market size and forecast, by Product and Service
    • 7.6.5.3.2. Market size and forecast, by Test Type
    • 7.6.5.3.3. Market size and forecast, by End User
    • 7.6.5.4. Rest Of Mea
    • 7.6.5.4.1. Market size and forecast, by Product and Service
    • 7.6.5.4.2. Market size and forecast, by Test Type
    • 7.6.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product mapping of top 10 player
• 8.4. Competitive dashboard
• 8.5. Competitive heatmap
• 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

• 9.1. Lonza Group AG
  • 9.1.1. Company overview
  • 9.1.2. Key executives
  • 9.1.3. Company snapshot
  • 9.1.4. Operating business segments
  • 9.1.5. Product portfolio
  • 9.1.6. Business performance
  • 9.1.7. Key strategic moves and developments
• 9.2. Thermo Fisher Scientific Inc.
  • 9.2.1. Company overview
  • 9.2.2. Key executives
  • 9.2.3. Company snapshot
  • 9.2.4. Operating business segments
  • 9.2.5. Product portfolio
  • 9.2.6. Business performance
  • 9.2.7. Key strategic moves and developments
• 9.3. Fujifilm Holdings Corporation
  • 9.3.1. Company overview
  • 9.3.2. Key executives
  • 9.3.3. Company snapshot
  • 9.3.4. Operating business segments
  • 9.3.5. Product portfolio
  • 9.3.6. Business performance
  • 9.3.7. Key strategic moves and developments
• 9.4. GenScript
  • 9.4.1. Company overview
  • 9.4.2. Key executives
  • 9.4.3. Company snapshot
  • 9.4.4. Operating business segments
  • 9.4.5. Product portfolio
  • 9.4.6. Business performance
  • 9.4.7. Key strategic moves and developments
• 9.5. SEIKAGAKU CORPORATION
  • 9.5.1. Company overview
  • 9.5.2. Key executives
  • 9.5.3. Company snapshot
  • 9.5.4. Operating business segments
  • 9.5.5. Product portfolio
  • 9.5.6. Business performance
  • 9.5.7. Key strategic moves and developments
• 9.6. Charles River Laboratories
  • 9.6.1. Company overview
  • 9.6.2. Key executives
  • 9.6.3. Company snapshot
  • 9.6.4. Operating business segments
  • 9.6.5. Product portfolio
  • 9.6.6. Business performance
  • 9.6.7. Key strategic moves and developments
• 9.7. STERIS plc
  • 9.7.1. Company overview
  • 9.7.2. Key executives
  • 9.7.3. Company snapshot
  • 9.7.4. Operating business segments
  • 9.7.5. Product portfolio
  • 9.7.6. Business performance
  • 9.7.7. Key strategic moves and developments
• 9.8. Wuxi AppTec
  • 9.8.1. Company overview
  • 9.8.2. Key executives
  • 9.8.3. Company snapshot
  • 9.8.4. Operating business segments
  • 9.8.5. Product portfolio
  • 9.8.6. Business performance
  • 9.8.7. Key strategic moves and developments
• 9.9. Eurofins Scientific SE
  • 9.9.1. Company overview
  • 9.9.2. Key executives
  • 9.9.3. Company snapshot
  • 9.9.4. Operating business segments
  • 9.9.5. Product portfolio
  • 9.9.6. Business performance
  • 9.9.7. Key strategic moves and developments
• 9.10. Merck KGaA
  • 9.10.1. Company overview
  • 9.10.2. Key executives
  • 9.10.3. Company snapshot
  • 9.10.4. Operating business segments
  • 9.10.5. Product portfolio
  • 9.10.6. Business performance
  • 9.10.7. Key strategic moves and developments

관련자료